| | Business Summary | | Norland
Medical
Systems,
Inc.
and
its
subsidiaries
develop,
manufacture,
sell
and
service
a
wide
range
of
bone
densitometers
used
to
assess
bone
mineral
content
and
density,
one
of
several
factors
used
by
physicians
to
aid
in
the
diagnosis
and
monitoring
of
bone
disorders,
particularly
osteoporosis.
Osteoporosis
progresses
as
a
symptomless
disease
characterized
by
bone
loss
and
deterioration
of
the
skeleton,
leading
to
bone
fragility
and
increased
risk
of
fracture.
Driven
by
the
availability
of
new
treatments
for
bone-related
disorders,
the
Company
is
focusing
on
bringing
affordable,
state-of-the-art
diagnostic
technology
directly
into
the
physician's
office
in
order
to
address
a
number
of
bone
health
issues. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Norland
Medical
Systems
develops,
manufactures,
markets,
sells,
distributes
and
services
a
broad
range
of
bone
densitometry
systems
used
to
diagnose
and
monitor
bone
diseases.
For
the
six
months
ended
6/30/01,
revenues
fell
35%
to
$5.1
million.
Net
loss
fell
94%
to
$698
thousand.
Revenues
reflect
lower
sales
of
DXA-based
bone
densitometry
systems.
Lower
loss
reflects
the
absence
of
a
$7.3
million
goodwill
expense
and
a
$4.1
million
deferred
income
tax
charge
due
to
impairment. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Reynald Bonmati, 53
Chairman,
Pres and Treasurer | $403K | Richard Rahn, 49
VP-Fin.,
Controller, Sec. | -- | Terry Pope, 49
VP,
Gen. Mang.--Ft. Atkinson Facility; and Assistant Sec. | 95K | Ralph Cozzolino, 54
VP
of Sales and Marketing | 152K | | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/n/nrld.ob.gif)